G1 Therapeutics Inc (GTHX)
3.71
-0.01
(-0.27%)
USD |
NASDAQ |
Apr 30, 09:51
G1 Therapeutics Free Cash Flow (Quarterly): -12.79M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -12.79M |
| September 30, 2023 | -10.58M |
| June 30, 2023 | 14.08M |
| March 31, 2023 | -29.05M |
| December 31, 2022 | -30.63M |
| September 30, 2022 | -21.25M |
| June 30, 2022 | -39.06M |
| March 31, 2022 | -38.18M |
| December 31, 2021 | -34.66M |
| September 30, 2021 | -34.08M |
| June 30, 2021 | -36.49M |
| March 31, 2021 | -26.88M |
| December 31, 2020 | -31.51M |
| September 30, 2020 | 3.639M |
| June 30, 2020 | -28.85M |
| March 31, 2020 | -27.02M |
| Date | Value |
|---|---|
| December 31, 2019 | -31.11M |
| September 30, 2019 | -26.35M |
| June 30, 2019 | -23.06M |
| March 31, 2019 | -21.76M |
| December 31, 2018 | -21.34M |
| September 30, 2018 | -17.22M |
| June 30, 2018 | -18.27M |
| March 31, 2018 | -18.18M |
| December 31, 2017 | -14.77M |
| September 30, 2017 | -13.99M |
| June 30, 2017 | -12.76M |
| March 31, 2017 | -9.293M |
| December 31, 2016 | -9.251M |
| September 30, 2016 | -5.409M |
| June 30, 2016 | -5.384M |
| March 31, 2016 | -5.347M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-39.06M
Minimum
Jun 2022
14.08M
Maximum
Jun 2023
-24.41M
Average
-28.85M
Median
Jun 2020
Free Cash Flow (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 1.727M |
| Geron Corp | -41.00M |
| Palatin Technologies Inc | -10.51M |
| Oragenics Inc | -1.102M |
| TG Therapeutics Inc | -13.21M |